Vyome (HIND) Proxy Filing summary
Event summary combining transcript, slides, and related documents.
Proxy Filing summary
15 Dec, 2025Executive summary
Special meeting will be held virtually for shareholders to vote on three key proposals, with record date set as February 18, 2025.
Proposals include a reverse stock split, approval of warrant exercisability, and approval of equity line of credit (ELOC) share issuance.
Board recommends voting FOR all proposals and outlines procedures for proxy voting and meeting participation.
Voting matters and shareholder proposals
Proposal 1: Authorize a reverse stock split at a ratio between 1-for-2 and 1-for-250, to be determined by the Board within one year.
Proposal 2: Approve exercisability of up to 2,703,862 warrants (potentially 15,132,975 shares) issued in a February 2025 offering, subject to Nasdaq rules.
Proposal 3: Approve issuance of up to 15,000,000 shares under a $5,000,000 ELOC agreement over 36 months, subject to Nasdaq rules.
Only shareholders of record as of February 18, 2025 may vote, with certain restrictions for investors involved in the warrant and ELOC agreements.
Board recommends voting FOR all proposals; abstentions count as votes against Proposals 2 and 3.
Board of directors and corporate governance
Board retains discretion to implement or abandon the reverse stock split within one year of approval.
Board may select the split ratio based on market conditions and other relevant factors.
Board can issue preferred stock with rights senior to common stock without further shareholder vote.
Shareholders can communicate with the Board via mail addressed to the company secretary.
Latest events from Vyome
- Net loss increased to $10.5M in 2025; cash runway to June 2027, further funding required.HIND
Q4 202518 Mar 2026 - Shareholders will vote on directors, an equity plan, auditor ratification, and executive pay.HIND
Proxy Filing15 Dec 2025 - Approval sought for reverse split, warrant exercise, and ELOC share issuance to support merger.HIND
Proxy Filing15 Dec 2025 - Shareholders to vote on reverse split, warrant exercise, and ELOC issuance to support listing and capital needs.HIND
Proxy Filing15 Dec 2025 - $5.7M cash, $9.2M net loss, positive VT-1953 data, and 2026 regulatory plans for VT-1908.HIND
Q3 202520 Nov 2025